Cargando…

Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer Risk

PURPOSE: Women with a family history of breast cancer are frequently referred for hereditary cancer genetic testing, yet < 10% are found to have pathogenic variants in known breast cancer susceptibility genes. Large-scale genotyping studies have identified common variants (primarily single-nucleo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hughes, Elisha, Tshiaba, Placede, Gallagher, Shannon, Wagner, Susanne, Judkins, Thaddeus, Roa, Benjamin, Rosenthal, Eric, Domchek, Susan, Garber, Judy, Lancaster, Johnathan, Weitzel, Jeffrey, Kurian, Allison W., Lanchbury, Jerry S., Gutin, Alexander, Robson, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2020
Materias:	Original Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446363/ https://www.ncbi.nlm.nih.gov/pubmed/32923876 http://dx.doi.org/10.1200/PO.19.00360

Ejemplares similares

Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer Genes
por: Gallagher, Shannon, et al.
Publicado: (2020)

Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic Testing
por: Hughes, Elisha, et al.
Publicado: (2021)

Comprehensive Breast Cancer Risk Assessment for CHEK2 and ATM Pathogenic Variant Carriers Incorporating a Polygenic Risk Score and the Tyrer-Cuzick Model
por: Gallagher, Shannon, et al.
Publicado: (2021)

Development and Validation of a Breast Cancer Polygenic Risk Score on the Basis of Genetic Ancestry Composition
por: Hughes, Elisha, et al.
Publicado: (2022)

Integration of a Cross-Ancestry Polygenic Model With Clinical Risk Factors Improves Breast Cancer Risk Stratification
por: Tshiaba, Placede T., et al.
Publicado: (2023)

Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancer
por: Patel, Jai N., et al.
Publicado: (2018)

Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer
por: Soliman, Hatem, et al.
Publicado: (2020)

Classification of genetic variants in genes associated with Lynch syndrome using a clinical history weighting algorithm
por: Morris, Brian, et al.
Publicado: (2016)

Validation of a Molecular and Pathological Model for Five-Year Mortality Risk in Patients with Early Stage Lung Adenocarcinoma
por: Bueno, Raphael, et al.
Publicado: (2015)

Polygenic risk for Alzheimer's disease shapes hippocampal scene-selectivity
por: Chandler, Hannah L., et al.
Publicado: (2020)

Multimodal hippocampal and amygdala subfield volumetry in polygenic risk for Alzheimer's disease
por: Murray, Amy N., et al.
Publicado: (2021)

The association between age at breast cancer diagnosis and prevalence of pathogenic variants
por: Daly, Mary B., et al.
Publicado: (2023)

Computational Method for Estimating DNA Copy Numbers in Normal Samples, Cancer Cell Lines, and Solid Tumors Using Array Comparative Genomic Hybridization
por: Abkevich, Victor, et al.
Publicado: (2010)

Polygenic risk modeling for prediction of epithelial ovarian cancer risk
por: Dareng, Eileen O., et al.
Publicado: (2022)

Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk
por: Dareng, Eileen O., et al.
Publicado: (2022)

Multiplex melanoma families are enriched for polygenic risk
por: Law, Matthew H, et al.
Publicado: (2020)

Derivation and internal validation of a multi-biomarker-based cardiovascular disease risk prediction score for rheumatoid arthritis patients
por: Curtis, Jeffrey R., et al.
Publicado: (2020)

Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk
por: Judkins, Thaddeus, et al.
Publicado: (2015)

Potential use of clinical polygenic risk scores in psychiatry – ethical implications and communicating high polygenic risk
por: Palk, A. C., et al.
Publicado: (2019)

Polygenic transcriptome risk scores (PTRS) can improve portability of polygenic risk scores across ancestries
por: Liang, Yanyu, et al.
Publicado: (2022)

Design and validation of an oligonucleotide microarray for the detection of genomic rearrangements associated with common hereditary cancer syndromes
por: Mancini-DiNardo, Debora, et al.
Publicado: (2014)

Association of BRCA1/2defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes
por: Timms, Kirsten M, et al.
Publicado: (2014)

Association Between Polygenic Risk Score and Risk of Myopia
por: Ghorbani Mojarrad, Neema, et al.
Publicado: (2019)

Polygenic risk scores in the clinic: Translating risk into action
por: Lewis, Anna C.F., et al.
Publicado: (2021)

Polygenic Risk Score and Risk Factors for Gestational Diabetes
por: Perišić, Marija Majda, et al.
Publicado: (2022)

Polygenic risk scores and breast cancer risk prediction
por: Roberts, Eleanor, et al.
Publicado: (2023)

PRSice: Polygenic Risk Score software
por: Euesden, Jack, et al.
Publicado: (2015)

Polygenic Hypercholesterolemia and Cardiovascular Disease Risk
por: Sharifi, Mahtab, et al.
Publicado: (2019)

Polygenic Risk Scores and Physical Activity
por: KUJALA, URHO M., et al.
Publicado: (2020)

Polygenic risk and pleiotropy in neurodegenerative diseases
por: Bellou, Eftychia, et al.
Publicado: (2020)

Polygenic Risk Scores for Subtyping of Schizophrenia
por: Chen, Jingchun, et al.
Publicado: (2020)

Polygenic risk scores and rheumatic diseases
por: Brown, Matthew A., et al.
Publicado: (2021)

New prevention scenarios: polygenic risk
por: Boccanelli, Alessandro, et al.
Publicado: (2021)

Polygenic Risk of Hypertriglyceridemia Is Modified by BMI
por: Esteve-Luque, Virginia, et al.
Publicado: (2022)

Polygenic Risk Score Prediction for Endometriosis
por: Kloeve-Mogensen, Kirstine, et al.
Publicado: (2021)

Performance of polygenic risk scores in screening, prediction, and risk stratification: secondary analysis of data in the Polygenic Score Catalog
por: Hingorani, Aroon D, et al.
Publicado: (2023)

Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing
por: Balmaña, Judith, et al.
Publicado: (2016)

Polygenic risk scores for prediction of breast cancer risk in Asian populations
por: Ho, Weang-Kee, et al.
Publicado: (2022)

Clinical significance of large rearrangements in BRCA1 and BRCA2
por: Judkins, Thaddeus, et al.
Publicado: (2012)

Polygenic impact of common genetic risk loci for Alzheimer’s disease on cerebral blood flow in young individuals
por: Chandler, Hannah L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3uitr423o8377q8g1d92br65qv